Search tool

EMCDDA–Europol Joint Report on a new psychoactive substance: MDPV (3,4-methylenedioxypyrovalerone)

The EMCDDA–Europol Joint Report on new psychoactive substance MDPV (3,4-methylenedioxypyrovalerone), submitted in December 2013 to the Council of the EU, the European Commission and the EMA. After assessing the available evidence, the...

EMCDDA–Europol Joint Report on a new psychoactive substance: methoxetamine (2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone)

The EMCDDA–Europol Joint Report on new psychoactive substance methoxetamine (2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone), submitted in December 2013 to the Council of the EU, the European Commission and the EMA. After assessing the available evidence, the...

EMCDDA–Europol Joint Report on new psychoactive substance AH-7921 (3,4-dichloro-N-[[1-(dimethylamino)cyclohexyl]methyl]benzamide)

The EMCDDA–Europol Joint Report on new psychoactive substance AH-7921 (3,4-dichloro-N-[[1-(dimethylamino)cyclohexyl]methyl]benzamide), submitted in December 2013 to the Council of the EU, the European Commission and the EMA. After assessing the available evidence, the...

Implementation reports

EMCDDA–Europol 2012 Annual Report on the implementation of Council Decision 2005/387/JHA (New drugs in Europe, 2012)

pThis report presents the key activities performed by the EMCDDA and Europol in 2012 and includes details of all the relevant activities in support of the implementation of Council Decision 2005/387/JHA on...

Technical reports

EMCDDA Trendspotter study on fentanyl in Europe

The EMCDDA Trendspotter case study on Fentanyl in Europe was undertaken during September and October 2012. It culminated in an expert meeting in Lisbon on 9–10 October 2012. The aim of the...

Implementation reports

EMCDDA–Europol 2011 Annual Report on the implementation of Council Decision 2005/387/JHA

This report presents the results and outlines the key achievements for 2011 on the information exchange, risk-assessment and control of new psychoactive substances. New drugs were detected in the European Union in...

Implementation reports

EMCDDA–Europol 2010 Annual Report on the implementation of Council Decision 2005/387/JHA

This report presents the results and outlines the key achievements for 2010 on the information exchange, risk-assessment and control of new psychoactive substances. In 2010, 41 new psychoactive substances were officially notified...

Implementation reports

EMCDDA–Europol 2009 Annual Report on the implementation of Council Decision 2005/387/JHA

This report presents the results and outlines the key achievements and challenges faced by mechanism set up by the Council Decision in 2009. In 2009, 24 new psychoactive substances were officially notified...

Europol–EMCDDA Joint Report on a new psychoactive substance: 4-methylmethcathinone (mephedrone)

In January 2010, increased evidence of the availability and use of mephedrone (4- methylmethcathinone) prompted the EMCDDA and Europol to launch a procedure for the production of a Joint Report. Pursuant to...

Thematic papers

Understanding the 'Spice' phenomenon

Smokable herbal mixtures under the brand name ‘Spice’ are known to have been sold on the Internet and in various specialised shops since at least 2006 and anecdotal reports suggest that those...